What is Masimo Corporation (MASI)?

Masimo Corporation (MASI) is a stock in the Healthcare sector, Medical - Devices industry. View full analysis on Stocks360.

What is the current price of MASI?

The current price of MASI is $179.95. Prices are updated in real time on Stocks360.

What is MASI's price-to-earnings (PE) ratio?

MASI's trailing twelve-month PE ratio is 124.97, based on current price and earnings per share data available on Stocks360.

What is MASI's market capitalization?

MASI's market capitalization is $9,423,817,026.00, placing it in the mid-cap tier.

Masimo Corporation (MASI)

Stock analysis · NASDAQ · Healthcare · Medical - Devices

$179.95

Market Cap

$9.42B

PE (TTM)

124.97

EPS (TTM)

N/A

Dividend Yield

0.00%

Beta

1.18

Day Range

$179.95 – $179.95

52-wk Range

$125.94 – $179.99

Avg Volume

N/A

Volume

0.00

Masimo Corporation (MASI) is a publicly traded company in the Healthcare sector. Latest price: $179.95. Market cap $9.42B. Trailing PE 124.97. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

1-Year Price

2025-10-31 · $140.65 2026-06-12 · $179.95 (+27.94%)

Earnings

Most Recent

May 5, 2026

EPS $1.43 vs est. $1.41

Beat by $0.02

Proprietary Signals

Signal snapshot temporarily unavailable.

About Masimo Corporation

Masimo Corporation engages in the development, manufacture, and marketing of various patient monitoring technologies, and automation and connectivity solutions worldwide. It offers Masimo Signal Extraction Technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo Rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of oxygen, carboxyhemoglobin, and methemoglobin. It also provides brain function and hemodynamic monitoring solutions; patient position and activity tracking, and neuromodulation technology solutions; and Masimo Hospital Automation platform, including hospital automation solutions, including Patient SafetyNet, Iris, iSirona, Replica, and UniView; and brain function monitoring, hemodynamic monitoring, regional oximetry, acoustic respiration rate monitoring, capnography and gas monitoring, and telehealth solutions. In addition, the company provides its products through direct sales force, distributors, and original equipment manufacturers partners to hospitals, emergency medical service and home care p…

Valuation

Trailing twelve months. Multiples relative to current market price.
P/E (TTM)	124.97×
P/S (TTM)	6.05×
P/B	11.91×
PEG	0.49×
P/FCF (TTM)	45.13×
EV / EBITDA	28.40×
EV / Sales	6.28×
Earnings Yield	0.81%
Free Cash Flow Yield	2.22%

Fundamentals

Trailing twelve months. Source: financial statements via market data.
Enterprise Value	$9.79B
Revenue (TTM)	$1.56B
Net Income (TTM)	$76.55M
Free Cash Flow (TTM)	$233.77M
Net Debt	$361.30M
Working Capital	$545.10M
Gross Margin	61.73%
Operating Margin	19.85%
Net Margin	4.90%
Return on Equity	9.08%
Return on Invested Capital	18.28%